Nigel Theobald

Nigel Theobald

Gründer bei N4 PHARMA PLC

Vermögen: 135 171 $ am 31.05.2024

59 Jahre
Health Technology
Consumer Services
Finance

Ursprung des Netzwerks ersten Grades von Nigel Theobald

EinheitArt der EinheitIndustrie
Public Company Biotechnology 5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Nigel Theobald

UnternehmenSektorVerknüpfte PersonenHauptposition
MEDISTEM INC Medical Specialties

John Chiplin

Director/Board Member

Medical/Nursing Services

Paul Titley

Corporate Officer/Principal

Pharmaceuticals: Major

John Chiplin

Director/Board Member

Pharmaceuticals: Major

David Templeton

Corporate Officer/Principal

Miscellaneous Commercial Services

Luke Sebastian Cairns

Corporate Officer/Principal

LIONSGOLD LTD Precious Metals

Luke Sebastian Cairns

Director/Board Member

Pharmaceuticals: Major

John Chiplin

Director/Board Member

Investment Banks/Brokers

Luke Sebastian Cairns

Corporate Officer/Principal

TBG DIAGNOSTICS LIMITED Pharmaceuticals: Major

John Chiplin

President

Pharmaceuticals: Generic

Chris Britten

Corporate Officer/Principal

Miscellaneous Commercial Services

Paul Titley

Corporate Officer/Principal

POLYNOVO LIMITED Biotechnology

John Chiplin

Director/Board Member

Biotechnology

John Chiplin

Director/Board Member

Miscellaneous Commercial Services

John Chiplin

Chairman

The University of Nottingham College/University

John Chiplin

Doctorate Degree

SEED INNOVATIONS LIMITED Investment Managers

Luke Sebastian Cairns

Director/Board Member

MANALTO LIMITED Packaged Software

John Chiplin

Director/Board Member

CYNATA THERAPEUTICS LIMITED Biotechnology

John Chiplin

Director/Board Member

Miscellaneous Commercial Services

Chris Britten

Director/Board Member

Pharmaceuticals: Major

Paul Titley

Chief Executive Officer

SCANCELL HOLDINGS PLC Biotechnology

John Chiplin

Chairman

Miscellaneous Commercial Services

David Templeton

Corporate Officer/Principal

Biotechnology

John Chiplin

Chief Executive Officer

Investment Managers

Luke Sebastian Cairns

Private Equity Investor

Miscellaneous Commercial Services

Chris Britten

Corporate Officer/Principal

Pharmaceuticals: Major

Chris Britten

Corporate Officer/Principal

Financial Conglomerates

John Chiplin

Director/Board Member

Investment Banks/Brokers

Luke Sebastian Cairns

Corporate Officer/Principal

Electronics Distributors

John Chiplin

Director/Board Member

SIENNA CANCER DIAGNOSTICS LIMITED Biotechnology

John Chiplin

Director/Board Member

ADALTA LIMITED Biotechnology

John Chiplin

Director/Board Member

ADVANZ PHARMA CORP. LIMITED Pharmaceuticals: Major

Chris Britten

Corporate Officer/Principal

Coma Research Institue

John Chiplin

Director/Board Member

Investment Managers

Chris Britten

Corporate Officer/Principal

Newstar Ventures Ltd.

John Chiplin

Founder

LSC Advisory Ltd

Luke Sebastian Cairns

Founder

Financial Conglomerates

Luke Sebastian Cairns

Director/Board Member

Finance/Rental/Leasing

Luke Sebastian Cairns

Director/Board Member

Pharmaceuticals: Major

John Chiplin

Chairman

Neuraxpharm UK Ltd.

Chris Britten

Corporate Officer/Principal

Packaged Software

John Chiplin

Chairman

Movies/Entertainment

Luke Sebastian Cairns

Director/Board Member

Wholesale Distributors

Chris Britten

Chief Operating Officer

Statistik

International

Vereinigtes Königreich 29
Vereinigte Staaten 11
Australien 10
Schweiz 2
Frankreich 2

Sektoral

Health Technology 21
Finance 12
Commercial Services 7
Consumer Services 3
Technology Services 3

Operativ

Director/Board Member 33
Corporate Officer/Principal 15
Independent Dir/Board Member 11
Chairman 7
Chief Executive Officer 4
  1. Börse
  2. Insiders
  3. Nigel Theobald
  4. Unternehmensverbindungen